NCT04703244View on ClinicalTrials.gov

Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 13, 2021

Primary Completion Date

January 15, 2041

Study Completion Date

January 15, 2042

Conditions
Breast CancerResidual
Interventions
PROCEDURE

chemotherapy or endocrine therapy for breast cancer

Collect blood and leftover surgical tissue from patients with breast cancer remaining after chemotherapy or endocrine therapy is completed.

Trial Locations (1)

55905

RECRUITING

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT04703244 - Development of Patient Derived Xenografts (PDX) in Patients With Breast Cancer | Biotech Hunter | Biotech Hunter